TBIO.jpg
Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development
03 août 2021 01h00 HE | Translate Bio, Inc.
-- Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas -- -- Fast tracks establishment of Sanofi’s recently announced mRNA Center...
Roots-Analysis-Logo.png
The global mRNA therapeutics and vaccines market is projected to be worth around USD 10 billion in 2021, claims Roots Analysis
09 févr. 2021 09h12 HE | Roots Analysis
London, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “mRNA Therapeutics and Vaccines Market, 2020-2030” report to its list of offerings. With over 150 candidates...
TBIO.jpg
Translate Bio to Participate in Upcoming Investor Conferences
29 sept. 2020 16h05 HE | Translate Bio, Inc.
LEXINGTON, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
TBIO.jpg
Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
06 août 2020 16h14 HE | Translate Bio, Inc.
-- Expanded collaboration with partner Sanofi Pasteur for all infectious diseases further unites Translate Bio’s leading mRNA technology and large-scale manufacturing with Sanofi’s world class vaccine...
TBIO.jpg
Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
20 juil. 2020 16h05 HE | Translate Bio, Inc.
LEXINGTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
TBIO.jpg
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
23 juin 2020 00h59 HE | Translate Bio, Inc.
-- The two companies will build upon their existing collaboration to pursue novel mRNA vaccines aimed at broadly addressing current and future infectious diseases -- -- Translate Bio to receive...